Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	19.02B
Revenue (ttm)	1.06B
Net Income (ttm)	147.98M
Shares Out	65.86M
EPS (ttm)	2.22
PE Ratio	130.16
Forward PE	66.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	78,826
Average Volume	96,849
Open	288.40
Previous Close	288.80
Day's Range	288.20 - 295.60
52-Week Range	244.00 - 405.80
Beta	0.60
RSI	40.32
Earnings Date	Oct 23, 2025

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; CERAMENT V, an injectable ceramic bone graft substitute t...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 139
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2024, Bonesupport Holding AB's revenue was 898.73 million, an increase of 52.05% compared to the previous year's 591.08 million. Earnings were 133.75 million, a decrease of -45.41%.